Faruqi & Faruqi, LLP, a U.S.-based securities litigation firm, has launched an investigation into PepGen Inc. $PEPG over alleged violations of federal securities laws. A class action lawsuit has been filed, with investors given until August 11, 2025, to apply for lead plaintiff status. The complaint alleges that PepGen and certain executives made false or misleading statements and omitted material facts in their communications with shareholders. The investigation focuses on whether PepGen misled investors regarding its operations, financial outlook, or drug development pipeline, potentially inflating its stock price.